Materials from peptide assembly: Towards the treatment of cancer and transmittable disease

Current Opinion in Chemical Biology

Volumn 15, Issue 3, 2011, Pages 427-434

  Branco, Monica C ^a   Sigano, Dina M ^a   Schneider, Joel P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DNA BINDING PROTEIN; HOX PROTEIN; LYSYLLEUCYLALANYLLYSINE; NANOPARTICLE; PEPTIDE; PROVENGE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CANCER CELL; CANCER THERAPY; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; HUMAN; MICELLE; NANOANALYSIS; NEOPLASM; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; REVIEW; VIRUS LIKE AGENT;

ANIMALS; CANCER VACCINES; COMMUNICABLE DISEASES; DRUG DESIGN; HUMANS; NEOPLASMS; PEPTIDES;

EID: 79957985973     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2011.03.021     Document Type: Review

References (57)

1. Borghaei H., Smith M.R., Campbell K.S. Immunotherapy of cancer. Eur J Pharmacol 2009, 625:41-54.
2. Klippstein R., Pozo D. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomed: Nanotechnol Biol Med 2010, 6:523-529.
3. Pellegrini M., Mak T.W., Ohashi P.S. Fighting cancers from within: augmenting tumor immunity with cytokine therapy. Trends Pharmacol Sci 2010, 31:356-363.
4. Anderson R., Tintinger G., Cockeran R., Potjo M., Feldman C. Beneficial and harmful interactions of antibiotics with microbial pathogens and the host innate immune system. Pharmaceuticals 2010, 3:1694-1710.
5. Mills K.H.G. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction. Immunol Lett 2009, 122:108-111.
6. Donadio S., Maffioli S., Monciardini P., Sosio M., Jabes D. Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot 2010, 63:423-430.
7. Murphy J.F. Trends in cancer immunotherapy. Clin Med Insights: Oncol 2010, 4:67-80.
8. Rajagopal K., Schneider J.P. Self-assembling peptides and proteins for nanotechnological applications. Curr Opin Struct Biol 2004, 14:480-486.
9. Collier J.H. Modular self-assembling biomaterials for directing cellular responses. Soft Matter 2008, 4:2310-2315.
10. Branco M.C., Schneider J.P. Self-assembling materials for therapeutic delivery. Acta Biomater 2009, 5:817-831.
11. Kopecek J., Yang J.Y. Peptide-directed self-assembly of hydrogels. Acta Biomater 2009, 5:805-816.
12. Segers V.F.M., Lee R.T. Local delivery of proteins and the use of self-assembling peptides. Drug Discovery Today 2007, 12:561-568.
13. Woolfson D.N. Building fibrous biomaterials from alpha-helical and collagen-like coiled-coil peptides. Biopolymers 2010, 94:118-127.
14. Tamerler C., Khatayevich D., Gungormus M., Kacar T., Oren E.E., Hnilova M., Sarikaya M. Molecular biomimetics: GEPI-based biological routes to technology. Biopolymers 2010, 94:78-94.
15. Cui H.G., Webber M.J., Stupp S.I. Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers 2010, 94:1-18.
16. Galler K.M., Aulisa L., Regan K.R., D'Souza R.N., Hartgerink J.D. Self-assembling multidomain peptide hydrogels: designed susceptibility to enzymatic cleavage allows enhanced cell migration and spreading. J Am Chem Soc 2010, 132:3217-3223.
17. Krishna O.D., Kiick K.L. Protein- and peptide-modified synthetic polymeric biomaterials. Biopolymers 2010, 94:32-48.
18. MacEwan S.R., Chilkoti A. Elastin-like polypeptides: biomedical applications of tunable biopolymers. Biopolymers 2010, 94:60-77.
19. Chow D., Nunalee M.L., Lim D.W., Simnick A.J., Chilkoti A. Peptide-based biopolymers in biomedicine and biotechnology. Mater Sci Eng: R: Reports 2008, 62:125-155.
20. McGregor D.P. Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 2008, 8:616-619.
21. Reichert J. Development Trends for Peptide Therapeutics 2010, Peptide Therapeutics Foundation (PTF), San Diego, CA.
22. Tiefenbrunn T.K., Dawson P.E. Chemoselective ligation techniques: modern applications of time-honored chemistry. Biopolymers 2010, 94:95-106.
23. Rughani R.V., Schneider J.P. Molecular design of beta-hairpin peptides for material construction. MRS Bull 2008, 33:530-535.
24. Zhang S.G., Marini D.M., Hwang W., Santoso S. Design of nanostructured biological materials through self-assembly of peptides and proteins. Curr Opin Chem Biol 2002, 6:865-871.
25. Jung J.P., Gasiorowski J.Z., Collier J.H. Fibrillar peptide gels in biotechnology and biomedicine. Biopolymers 2010, 94:49-59.
26. Rudra J.S., Tian Y.F., Jung J.P., Collier J.H. A self-assembling peptide acting as an immune adjuvant. Proc Natl Acad Sci USA 2010, 107:622-627.
27. Lee J.-h., Choi Y.J., Lim Y.-b. Self-assembled filamentous nanostructures for drug/gene delivery applications. Exp Opin Drug Deliv 2010, 7:341-351.
28. Wu K., Liu J., Johnson R.N., Yang J., Kopeček J. Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface. Angew Chem Int Ed 2010, 49:1451-1455.
29. Bugge T.H., Antalis T.M., Affara N.I., Andreu P., Coussens L.M. Delineating protease functions during cancer development. Proteases and Cancer. Methods in Molecular Biology 2009, vol 539:1-32. Humana Press.
30. van Kempen L.C.L., de Visser K.E., Coussens L.M. Inflammation, proteases and cancer. Eur J Cancer 2006, 42:728-734.
31. Iiizumi M., Liu W., Pai S.K., Furuta E., Watabe K. Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy. Biochim Biophys Acta (BBA)-Rev Cancer 2008, 1786:87-104.
32. Liu C., He X. Destruction of a destructor: a new avenue for cancer therapeutics targeting the Wnt pathway. J Mol Cell Biol 2010, 2:70-73.
33. Young A, Lyons J, Miller AL, Phan VT, Alarcón IR, McCormick F: Ras signaling and therapies. In: Advances in Cancer Research, Vande Woude GF, Klein, G. (Eds.) Academic Press; 2009, 102:1-17.
34. Chen L.S., Balakrishnan K., Gandhi V. Inflammation and survival pathways: Chronic lymphocytic leukemia as a model system. Biochem Pharmacol 2010, 80:1936-1945.
35. Yang Z.M., Xu K.M., Guo Z.F., Guo Z.H., Xu B. Intracellular enzymatic formation of nanofibers results in hydrogelation and regulated cell death. Adv Mater 2007, 19:3152-3156.
36. Torchilin V.: Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev, in press.
37. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjugate Chem 2010, 21:797-802.
38. Maeda H., Bharate G.Y., Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharmaceut Biopharmaceut 2009, 71:409-419.
39. Standley S.M., Toft D.J., Cheng H., Soukasene S., Chen J., Raja S.M., Band V., Band H., Cryns V.L., Stupp S.I. Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res 2010, 70:3020-3026.
40. Missirlis D., Krogstad D.V., Tirrell M. Internalization of p53(14-29) peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death. Mol Pharmaceut 2010, 7:2173-2184.
41. Aulisa L., Forraz N., McGuckin C., Hartgerink J.D. Inhibition of cancer cell proliferation by designed peptide amphiphiles. Acta Biomater 2009, 5:842-853.
42. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infectious Dis 2001, 1:156-164.
43. Kindrachuk J., Napper S. Structure-activity relationships of multifunctional host defence peptides. Mini Rev Med Chem 2010, 10:596-614.
44. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002, 66:236-248.
45. Liu L.H., Xu K.J., Wang H.Y., Tan P.K.J., Fan W.M., Venkatraman S.S., Li L.J., Yang Y.Y. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nature Nanotechnol 2009, 4:457-463.
46. Yang Z., Liang G., Guo Z., Guo Z., Xu B. Intracellular hydrogelation of small molecules inhibits bacterial growth. Angew Chem Int Ed 2007, 46:8216-8219.
47. Salick D.A., Kretsinger J.K., Pochan D.J., Schneider J.P. Inherent antibacterial activity of a peptide-based beta-hairpin hydrogel. J Am Chem Soc 2007, 129:14793-14799.
48. Salick D.A., Pochan D.J., Schneider J.P. Design of an injectable beta-hairpin peptide hydrogel that kills methicillin-resistant Staphylococcus aureus. Adv Mater 2009, 21:4120.
49. Perez S.A., von Hofe E., Kallinteris N.L., Gritzapis A.D., Peoples G.E., Papamichail M., Baxevanis C.N. A new era in anticancer peptide vaccines. Cancer 2010, 116:2071-2080.
50. Mocellin S., Pilati P., Nitti D. Peptide-based anticancer vaccines: recent advances and future perspectives. Curr Med Chem 2009, 16:4779-4796.
51. Rudra J.S., Tripathi P.K., Hildeman D.A., Jung J.P., Collier J.H. Immune responses to coiled coil supramolecular biomaterials. Biomaterials 2010, 31:8475-8483.
52. Tang A., Kopecek J. Presentation of epitopes on genetically engineered peptides and selection of lymphoma-targeting moieties based on epitope biorecognition. Biomacromolecules 2002, 3:421-431.
53. Tang A.J., Wang C., Stewart R., Kopecek J. Self-assembled peptides exposing epitopes recognizable by human lymphoma cells. Bioconjugate Chem 2000, 11:363-371.
54. Perriman A.W., Williams D.S., Jackson A.J., Grillo I., Koomullil J.M., Ghasparian A., Robinson J.A., Mann S. Synthetic virus-like particles and hybrid constructs based on lipopeptide self-assembly. Small 2010, 6:1191-1196.
55. Boato F., Thomas R.M., Ghasparian A., Freund-Renard A., Moehle K., Robinson J.A. Synthetic virus-like particles from self-assembling coiled-coil lipopeptides and their use in antigen display to the immune system. Angew Chem Int Ed 2007, 46:9015-9018.
56. Kaba S.A., Brando C., Guo Q., Mittelholzer C., Raman S., Tropel D., Aebi U., Burkhard P., Lanar D.E. A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria. J Immunol 2009, 183:7268-7277.
57. Pimentel T., Yan Z., Jeffers S.A., Holmes K.V., Hodges R.S., Burkhard P. Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine. Chem Biol Drug Des 2009, 73:53-61.